SEC Filing Summary: Griffin-American Healthcare REIT IV, Inc.
Business Context and Reporting Period
This Form 8-K was filed on April 22, 2021, by Griffin-American Healthcare REIT IV, Inc. The filing serves as a Regulation FD disclosure to distribute the company's Fourth Quarter and Year-End 2020 Investor Update Letter. The registrant is incorporated in Maryland and is designated as an emerging growth company.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Exhibit 99.1 (Investor Update Letter), which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It solely announces the release of the Q4 and Year-End 2020 update.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, and risk factors are located in the attached Investor Update Letter (Exhibit 99.1). The 8-K text itself does not provide specific details on these items. The filing notes that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Fourth Quarter and Year-End 2020 Investor Update Letter) for actual financial performance data.
- Verify the specific occupancy rates and rental income figures for the Q4 2020 period in the attached letter.
- Confirm the status of the company's debt obligations and liquidity position as detailed in the investor update.
- Check for any new risk factors or operational challenges discussed in the management commentary of the attached exhibit.